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AUTHOR'S SUMMARY
The Korean Society of Cardiology has recently published the Korea Heart Disease Fact Sheet 
2020 to provide overview of the cardiovascular disease (CVD) burden and its temporal 
changes. CVD mortality, hospitalization, and risk factor distributions were analyzed 
from nationwide databases. Over the last decade, CVD mortality and hospitalization have 
increased, while their age-standardized rates have declined. In addition, a considerable 
proportion of adults had multiple risk factors, which markedly increased with older age. 
Thus, concerted efforts should be continued to address the rising burden of CVD in Korea.
ABSTRACT
Background and Objectives: Cardiovascular disease (CVD) is the leading cause of death and 
disability worldwide. To provide an overview of the temporal trends in the burden of CVD, 
the Korean Society of Cardiology has published the Korea Heart Disease Fact Sheet in 2020.
Methods: We analyzed anonymized data of the Causes of Death Statistics, National Health 
Insurance Claims Database, and Korea National Health and Nutrition Examination Survey to 
assess mortality, hospitalizations, and risk factors for CVD.
Results: The CVD mortality decreased until 2010, then steadily increased up to 123 per 
100,000 persons in 2018. Since 2002, the number and rate of CVD hospitalization have 
continued to grow. In 2018, approximately 12.1 million Korean adults had hypertension, 4.3 
million had diabetes, 8.7 million had hypercholesterolemia, 14.9 million had obesity, and 8.8 
million were currently smoking. The number of risk factors increased markedly with older 
age; 58.4% of adults age ≥70 years had ≥2 risk factors.
Conclusions: CVD mortality and hospitalization have gradually increased in the last decade, 
and a substantially high proportion of adults were carrying more than 1 cardiovascular 
risk factor in 2018. With the rapid population aging, a continued increase in CVD appears 
inevitable in Korea. Concerted and sustained approaches are essential to achieve early 
prevention and reduce the burden of CVD.
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INTRODUCTION
Cardiovascular disease (CVD) is the leading cause of death worldwide, accounting for nearly 
one-third of all deaths.1)2) The same holds true for Korea, where heart disease has been the 
leading cause of death for nearly a decade.3) Since a significant portion of CVD is preventable, 
the importance of adequate prevention strategies has long been emphasized.4) To implement 
such strategies and subsequently reduce the burden of CVD, magnitude and temporal trends 
in mortality, morbidity, and risk factors of CVD need to be clearly identified. In Korea, the 
Statistics Korea (formerly the National Statistical Office) has annually released anonymized 
data on the causes of death since 1983 based on the death registry.3) The temporal trend in 
CVD mortality has been repeatedly reported with this data.5-7) On the contrary, nationally 
representative data on CVD morbidity are extremely limited, making it difficult to accurately 
assess the incidence and prevalence of CVD in Korea. Although there have been several studies 
estimating the burden of CVD using the National Health Insurance claims data that cover the 
entire Korean population,8-13) most of the studies were confined to specific disease categories, 
such as myocardial infarction (MI),8)9) cerebrovascular diseases,10)11) or heart failure (HF).12)13) 
Moreover, substantial heterogeneity in study methods makes it inappropriate to compare their 
results directly. Regarding cardiovascular risk factors, fact sheets describing the prevalence and 
management status of hypertension, diabetes, dyslipidemia, obesity, and metabolic syndrome 
have been published by affiliated academic societies of Korea.14-18) Nonetheless, comprehensive 
data summarizing the overall status of CVD in Korea has not been reported yet. Thus, we 
analyzed the temporal trends in CVD mortality, hospitalization, and risk factors based on 
nationally representative datasets on behalf of the Korean Society of Cardiology.
METHODS
Ethical statement
The present study complied with the Declaration of Helsinki and was approved by the 
Institutional Review Board of Yonsei University Health System, Seoul, Korea (No. 4-2020-
0207). Informed consent was waived since this is a retrospective study of de-identified 
administrative data.
Classification of circulatory system diseases
All diseases of circulatory system were categorized into heart diseases, cerebrovascular 
diseases, and other circulatory diseases. Heart diseases were further classified into 
subcategories, including ischemic heart diseases (IHD), HF, and hypertension. MI was 
considered a subcomponent of IHD. The overall classification scheme and corresponding 
International Classification of Diseases-10 (ICD-10) codes are presented in Table 1.
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Table 1. Classification of cardiovascular diseases
Disease category ICD codes (10th revision)
All diseases of circulatory system I00–I99
Heart diseases I00–I13, I20–I28, I30–I51





Other circulatory diseases I15, I52, I70–I99
ICD, International Classification of Diseases.
Assessment of cardiovascular disease mortality
The Korean Statistical Information Service-Microdata Integrated Service (KOSIS-MDIS) 
covers the entire resident-registered population and a portion of unidentified individuals 
in Korea. Based on mortality data provided by the KOSIS-MDIS, we calculated the annual 
CVD mortality rate between 1983 and 2018. In addition, age-standardization was performed 
by the direct method to adjust for changing population structures over time. Specifically, 
the standardization was performed with the population structure of the resident-registered 
population in 2018 as a reference, separately by sex.
Assessment of cardiovascular disease hospitalizations
Using National Health Insurance Big Data (NHIBD), we evaluated the magnitude and temporal 
trends of CVD hospitalizations between 2002 and 2018 among adults aged ≥20 years covered 
by the National Health Insurance.19) For each year, we estimated the number of people 
hospitalized for CVDs. Then, CVD hospitalization rate was defined as the number of people 
hospitalized for CVD over the total number of insured people in that year. Age-standardized 
hospitalization rates were calculated with the direct method based on the population structure 
of insured people in 2018. As a diagnosis code for hospitalization can be recorded either as a 
primary diagnosis or other diagnoses, numbers of adults hospitalized for CVDs were estimated 
separately based on (1) primary diagnosis and (2) all diagnoses during hospitalization.
Assessment of cardiovascular risk factors
Using the Korea National Health and Nutrition Examination Survey (KNHANES) data, 
we assessed the current CVD risk factor distribution among adults aged ≥20 years who 
completed the KNHANES in 2018. The five major CVD risk factors included hypertension, 
diabetes, hypercholesterolemia, obesity, and current smoking (Table 2). We estimated the 
number of adults with each risk factor based on the weighted prevalence calculated from the 
KNHANES data. The number of adults with dyslipidemia was also assessed. Subsequently, 
we categorized the participants by the number of major risk factors (0, 1, 2, and ≥3) and 
examined its distribution by age and sex. All analyses of the KNHANES data accounted for 
the complex survey design adopted in the KNHANES to generate nationally representative 
estimates for the noninstitutionalized Korean population.20)
Statistical analysis
All statistical analyses were performed using SAS version 9.4 (SAS Institute Inc., Cary, NC, 
USA) and R version 4.0.3 (R Foundation for Statistical Computing, Vienna, Austria).
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Table 2. Definition of cardiovascular risk factors
Risk factor Definition
Hypertension (1) Systolic blood pressure ≥140 mmHg or
(2) Diastolic blood pressure ≥90 mmHg or
(3) Taking antihypertensive agent
Diabetes (1) Fasting blood glucose ≥126 mg/dL or
(2) Taking oral hypoglycemic agent or under insulin therapy
Hypercholesterolemia (1) Total cholesterol ≥240 mg/dL or
(2) Taking lipid-lowering agent
Obesity Body mass index ≥25 kg/m2
Current smoking Has smoked ≥100 cigarettes in lifetime and is currently smoking
Additionally, dyslipidemia was defined as (1) low-density lipoprotein cholesterol ≥160 mg/dL or (2) triglyceride 
≥200 mg/dL or (3) high-density lipoprotein cholesterol <40 mg/dL or (4) taking lipid-lowering agent.
RESULTS
Cardiovascular disease mortality
The mortality rate due to all diseases of circulatory system declined until 2010 and steadily 
increased afterward up to 123 per 100,000 persons in 2018 (Figure 1, Supplementary Table 1). 
Such shift is most likely due to population aging, as the age-standardized mortality rate has 
continued to decrease even after 2010 (Supplementary Figure 1). There was also a transient 
peak in circulatory system diseases mortality around 1994 when the ICD system was revised 
from 9th to 10th revision. In the last decade, mortality due to heart diseases, IHD, HF, and 
hypertension have increased. During the same period, mortality due to MI has been stagnant, 
whereas cerebrovascular diseases mortality has declined (Figure 1, Supplementary Table 1). 
Further details on the 36-year trend of mortality from diseases of circulatory system in Korea 
are presented elsewhere.21)
Hospitalization for cardiovascular diseases
Since 2002, the numbers of adults hospitalized for all diseases of circulatory system, heart 
diseases, and cerebrovascular diseases have consistently escalated based on both primary and 
all hospital diagnoses (Figure 2). Between 2002 and 2018, the number of people hospitalized 
increased 3.7 fold (from 169 thousand to 630 thousand) for all circulatory system diseases, 3.7 
fold (from 91 thousand to 333 thousand) for heart diseases, and 3.5 fold (from 65 thousand to 
227 thousand) for cerebrovascular diseases based on primary diagnosis (Figure 2A). Based on 
all hospital diagnoses, the number increased 4.5 fold (from 444 thousand to 1,994 thousand) 
for all circulatory system diseases, 4.1 fold (from 391 thousand to 1,600 thousand) for heart 
diseases, and 4.5 fold (from 105 thousand to 474 thousand) for cerebrovascular diseases 
(Figure 2B).
The hospitalization rate for all circulatory system diseases based on primary diagnosis also 
increased to 1,455 per 100,000 persons in 2018 (Figure 3A, Supplementary Table 2). The 
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Figure 1. Changes in cardiovascular disease mortality rate, 1983–2018.
hospitalization rates for heart diseases and those for cerebrovascular diseases increased 
until 2016; after that, the heart diseases hospitalization rate continued to grow, while the 
cerebrovascular diseases hospitalization rate started to decline. Among heart diseases, 
the hospitalization rate due to HF exhibited the greatest increase (3.5-fold), followed by 
hypertension (2.7-fold), IHD (2.6-fold), and MI (1.9-fold) (Figure 3A, Supplementary Table 2).
Again, such trends could be attributed in part to population aging in Korea. The age-
standardized hospitalization rates for all circulatory system diseases and their components 
had continually risen until 2009. (Figure 3B, Supplementary Table 3) Since then, the 
hospitalization rates for all circulatory system diseases, heart diseases, and cerebrovascular 
diseases have slowly declined. At the same time, the hospitalization rate for hypertension 
also decreased steadily, while the rate for HF declined until 2015 and increased thereafter. 
The hospitalization rate for IHD remained stagnant until 2012 then fluctuated. On the 
contrary, the hospitalization rate for MI decreased until 2011 then increased afterward 
(Figure 3B, Supplementary Table 3).
Cardiovascular risk factors
In 2018, approximately 12.1 million adults had hypertension, 4.3 million had diabetes, 8.7 
million had hypercholesterolemia, 14.9 million were obese, and 8.8 million were currently 
smoking (Figure 4). The proportion of people with ≥2 risk factors rapidly increased with 
older age, ranging from 14.7% in the age group of 20-29 years to 58.4% in the age group of 
≥70 years. Moreover, 27.8% of people aged ≥70 years had 3 or more cardiovascular risk factors 
(Figure 5A). This age-related trend was apparent in both sexes. Whereas men had a greater 
number of risk factors until age 70, the number surpassed among women at age >70 years 
(Figure 5B and C).
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Figure 2. Changes in the number of people hospitalized for cardiovascular disease, 2002–2018. Estimated based on (A) primary diagnosis and (B) all diagnoses 
during hospitalization.
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Figure 3. Changes in cardiovascular disease hospitalization rate, 2002–2018. (A) Crude rate. (B) Age-standardized 
rate. Age-standardization was performed by direct method with the population structure of insured people in 










Figure 4. Number of Korean adults with each cardiovascular risk factor, 2018.
DISCUSSION
CVD mortality has increased during the last decade in Korea. Such increment was mainly 
driven by heart diseases, while mortality due to cerebrovascular diseases has declined over 
the past 2 decades. Hospitalization for CVD has also continually increased, with every CVD 
category showing a 2-3-fold increase between 2002 and 2018. Age-standardization revealed 
that the aforementioned increases in mortality and hospitalization were attributable, at least 
in part, to the population aging in Korea. As to cardiovascular risk factors, a high proportion 
of Korean adults were carrying more than one risk factor, and the number of risk factors 
escalated with older age.
Considering the rapid population aging in Korea, the continued increase in CVD 
hospitalization and mortality appears inevitable. Moreover, the age-dependent distributions 
of cardiovascular risk factors imply an even greater burden predicted in the future. Thus, 
concerted and sustained efforts are crucial among healthcare professionals, policymakers, 
and the general population themselves to achieve early prevention and subsequently reduce 
the burden of CVD in Korea.
SUPPLEMENTARY MATERIALS
Supplementary Table 1
Changes in cardiovascular disease mortality rate, 1983–2018
Click here to view
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Figure 5. Number of cardiovascular risk factors by sex and age, 2018. (A) In all sex. (B) In men. (C) In women.
Supplementary Table 2
Changes in cardiovascular disease hospitalization rate, 2002–2018
Click here to view
Supplementary Table 3
Changes in age-standardized cardiovascular disease hospitalization rate, 2002–2018
Click here to view
Supplementary Figure 1
Changes in age-standardized cardiovascular disease mortality rate, 1983–2018. (A) In men. (B) In 
women. Age-standardization was performed by the direct method with the population structure 
of the resident-registered people in 2018 as a reference, separately for men and women.
Click here to view
Supplementary Data
Heart Disease Fact Sheet 2020
Click here to view
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